Trials / Conditions / Haemophilia A With Inhibitors

Haemophilia A With Inhibitors

29 registered clinical trials studyying Haemophilia A With Inhibitors.

Status	Trial	Sponsor	Phase
Completed	A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRO NCT05878938	Novo Nordisk A/S	Phase 3
Active Not Recruiting	A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4) NCT05685238	Novo Nordisk A/S	Phase 3
Completed	A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors NCT05053139	Novo Nordisk A/S	Phase 3
Active Not Recruiting	Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibit NCT04083781	Novo Nordisk A/S	Phase 3
Completed	A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explor NCT03741881	Novo Nordisk A/S	—
Completed	A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B NCT03196284	Novo Nordisk A/S	Phase 2
Completed	Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in NCT02541942	Novo Nordisk A/S	Phase 2
Completed	To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives NCT02241694	Novo Nordisk A/S	—
Withdrawn	Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects NCT02084810	Novo Nordisk A/S	Phase 1
Completed	Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia NCT01988532	Novo Nordisk A/S	—
Completed	A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B NCT01949792	Novo Nordisk A/S	Phase 1
Completed	Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries NCT01503567	Novo Nordisk A/S	—
Completed	Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors NCT01392547	Novo Nordisk A/S	Phase 3
Completed	Survey Evaluating the Psychosocial Effects of Living With Haemophilia NCT01322620	Novo Nordisk A/S	—
Completed	A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthope NCT01830712	Novo Nordisk A/S	—
Completed	Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibit NCT00951405	Novo Nordisk A/S	Phase 2
Completed	PROPACT: Retrospective Prophylaxis Patient Case Collection NCT00882778	Novo Nordisk A/S	—
Completed	Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors NCT00710619	Novo Nordisk A/S	—
Completed	Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and NCT00703911	Novo Nordisk A/S	—
Completed	Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects NCT01561417	Novo Nordisk A/S	Phase 1
Completed	Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Pa NCT01561924	Novo Nordisk A/S	Phase 1
Completed	Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia NCT00108758	Novo Nordisk A/S	Phase 2
Completed	High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia NCT00571584	Novo Nordisk A/S	Phase 4
Completed	Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers NCT01563471	Novo Nordisk A/S	Phase 1
Completed	Trial of NovoSeven® in Haemophilia - Joint Bleeds NCT00108797	Novo Nordisk A/S	Phase 4
Completed	Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal NCT01579955	Novo Nordisk A/S	—
Completed	Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoi NCT01579968	Novo Nordisk A/S	—
Completed	Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A an NCT01586936	Novo Nordisk A/S	—
Completed	Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During a NCT01561391	Novo Nordisk A/S	Phase 4